Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: The LIPSIA yukon trial

JACC: Cardiovascular Interventions

Volumn 4, Issue 4, 2011, Pages 452-459

  Desch, Steffen ^a   Schloma, Denis ^a   Mbius Winkler, Sven ^a   Erbs, Sandra ^a   Gielen, Stephan ^a   Linke, Axel ^a   Yu, Jiangtao ^b   Lauer, Bernward ^b   Kleinertz, Klaus ^c   Dnschel, Wilfried ^c   Schuler, Gerhard ^a   Thiele, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Zentralklinik Bad Berka ^*  (Germany)

^c Heart Center   (Germany)

Author keywords

diabetes mellitus; late lumen loss; paclitaxel; sirolimus; stents

Indexed keywords

PACLITAXEL; POLYMER; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY RECANALIZATION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; POLYMERS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955098400     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.11.016     Document Type: Article

References (25)

1. A.J. Kirtane, A. Gupta, and S. Iyengar Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies Circulation 119 2009 3198 3206
2. S. Garg, and P.W. Serruys Coronary stents: current status J Am Coll Cardiol 56 2010 S1 S42
3. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008 (Pubitemid 46376800)
4. J. Hausleiter, A. Kastrati, and R. Wessely Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating Eur Heart J 26 2005 1475 1481 (Pubitemid 41373487)
5. J. Mehilli, R.A. Byrne, A. Wieczorek ISAR-TEST-3 Investigators Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis Eur Heart J 29 2008 1975 1982
6. J. Mehilli, A. Kastrati, R. Wessely ISAR-TEST Investigators Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss Circulation 113 2006 273 279
7. G.W. Stone, S.G. Ellis, D.A. Cox TAXUS-IV Investigators A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231 (Pubitemid 38067635)
8. M.A. Turco, J.A. Ormiston, and J.J. Popma Polymer-based, paclitaxel-eluting Taxus Liberte stent in de novo lesions: the pivotal Taxus ATLAS trial J Am Coll Cardiol 49 2007 1676 1683 (Pubitemid 46589927)
9. University of Leipzig LIPSIA - TRIALS Randomisations und Erfassungs System http://www.uni-leipzig.de/∼kard/LIPSIA Accessed March 14, 2011
10. S.G. Ellis, M.G. Vandormael, M.J. Cowley Multivessel Angioplasty Prognosis Study Group Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease Implications for patient selection Circulation 82 1990 1193 1202
11. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878 (Pubitemid 29511140)
12. D.E. Cutlip, S. Windecker, R. Mehran Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344C51
13. A. Dibra, A. Kastrati, J. Mehilli ISAR-DIABETES Study Investigators Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670 (Pubitemid 41175674)
14. J.B. Hermiller, A. Raizner, L. Cannon TAXUS-IV Investigators Outcomes with the polymer-based paclitaxel-eluting Taxus stent in patients with diabetes mellitus: the Taxus-IV trial J Am Coll Cardiol 45 2005 1172 1179 (Pubitemid 40523133)
15. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 2002 S1 S266
16. S.W. Lee, S.W. Park, and Y.H. Kim A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol 52 2008 727 733
17. M. Maeng, L.O. Jensen, and A.M. Galloe Comparison of the sirolimus-eluting versus paclitaxel-eluting coronary stent in patients with diabetes mellitus: the diabetes and drug-eluting stent (DiabeDES) randomized angiography trial Am J Cardiol 103 2009 345 349
18. J. Ruef, H. Storger, F. Schwarz, and J. Haase Increased restenosis rates 12 months after coronary implantation of the sirolimus-eluting Yukon-choice stent compared to the paclitaxel-eluting Taxus stent Clin Cardiol 33 2010 E33 E38
19. R.A. Byrne, R. Iijima, and J. Mehilli Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer J Am Coll Cardiol Intv 2 2009 291 299
20. R.A. Byrne, S. Kufner, K. Tiroch ISAR-TEST-3 Investigators Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results Heart 95 2009 1489 1494
21. P. Moore, P. Barlis, and J. Spiro A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents J Am Coll Cardiol Intv 2 2009 437 444
22. S. Kaul, and G.A. Diamond Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials Prog Cardiovasc Dis 49 2007 284 299 (Pubitemid 44918059)
23. L. Mauri, E.J. Orav, S.C. Candia, D.E. Cutlip, and R.E. Kuntz Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials Circulation 112 2005 2833 2839 (Pubitemid 41641678)
24. T.R. Fleming, and D.L. DeMets Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125 1996 605 613 (Pubitemid 126450094)
25. F. Zhang, L. Dong, and J. Ge Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus Am J Cardiol 105 2010 64 68